Literature DB >> 26307349

Immunomodulatory properties of stem cells and bioactive molecules for tissue engineering.

Eric R Molina1, Brandon T Smith1, Sarita R Shah1, Heungsoo Shin2, Antonios G Mikos3.   

Abstract

The immune system plays a crucial role in the success of tissue engineering strategies. Failure to consider the interactions between implantable scaffolds, usually containing cells and/or bioactive molecules, and the immune system can result in rejection of the implant and devastating clinical consequences. However, recent research into mesenchymal stem cells, which are commonly used in many tissue engineering applications, indicates that they may play a beneficial role modulating the immune system. Likewise, direct delivery of bioactive molecules involved in the inflammatory process can promote the success of tissue engineering constructs. In this article, we will review the various mechanisms in which modulation of the immune system is achieved through delivered bioactive molecules and cells and contextualize this information for future strategies in tissue engineering.
Copyright © 2015 Elsevier B.V. All rights reserved.

Keywords:  Bioactive molecules; Cell delivery; Immunomodulation; Mesenchymal stem cell; Regenerative medicine; Tissue engineering

Mesh:

Year:  2015        PMID: 26307349     DOI: 10.1016/j.jconrel.2015.08.038

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  10 in total

Review 1.  Progress in three-dimensional printing with growth factors.

Authors:  Gerry L Koons; Antonios G Mikos
Journal:  J Control Release       Date:  2018-12-20       Impact factor: 9.776

Review 2.  Challenges in vascular tissue engineering for diabetic patients.

Authors:  Jhilmil Dhulekar; Agneta Simionescu
Journal:  Acta Biomater       Date:  2018-02-01       Impact factor: 8.947

Review 3.  Mesenchymal Stem Cell-Derived Extracellular Vesicles Promote Angiogenesis: Potencial Clinical Application.

Authors:  Consuelo Merino-González; Felipe A Zuñiga; Carlos Escudero; Valeska Ormazabal; Camila Reyes; Estefanía Nova-Lamperti; Carlos Salomón; Claudio Aguayo
Journal:  Front Physiol       Date:  2016-02-09       Impact factor: 4.566

Review 4.  Designing biomaterials with immunomodulatory properties for tissue engineering and regenerative medicine.

Authors:  James I Andorko; Christopher M Jewell
Journal:  Bioeng Transl Med       Date:  2017-05-16

Review 5.  Cartilage repair by mesenchymal stem cells: Clinical trial update and perspectives.

Authors:  Wayne Yuk-Wai Lee; Bin Wang
Journal:  J Orthop Translat       Date:  2017-04-09       Impact factor: 5.191

6.  Challenges for Mesenchymal Stem Cell-Based Therapy for COVID-19.

Authors:  Chenghai Li; Hua Zhao; Bin Wang
Journal:  Drug Des Devel Ther       Date:  2020-09-29       Impact factor: 4.162

Review 7.  The role of mesenchymal stem cells in the occurrence, development, and therapy of hepatocellular carcinoma.

Authors:  Xiaoli Zhang; Na Li; Ying Zhu; Wei Wen
Journal:  Cancer Med       Date:  2022-01-03       Impact factor: 4.452

Review 8.  The potential use of mesenchymal stem cells and their exosomes in Parkinson's disease treatment.

Authors:  Reza Mosaddeghi Heris; Milad Shirvaliloo; Sanaz Abbaspour-Aghdam; Ali Hazrati; Ali Shariati; Hamed Rahmani Youshanlouei; Farhad Jadidi Niaragh; Hamed Valizadeh; Majid Ahmadi
Journal:  Stem Cell Res Ther       Date:  2022-07-28       Impact factor: 8.079

9.  The observed difference of macrophage phenotype on different surface roughness of mineralized collagen.

Authors:  Jun Li; Yu-Jue Zhang; Zhao-Yong Lv; Kun Liu; Chun-Xiu Meng; Bo Zou; Ke-Yi Li; Feng-Zhen Liu; Bin Zhang
Journal:  Regen Biomater       Date:  2020-01-25

Review 10.  Stem Cells and the Endometrium: From the Discovery of Adult Stem Cells to Pre-Clinical Models.

Authors:  Lucía de Miguel-Gómez; Sara López-Martínez; Emilio Francés-Herrero; Adolfo Rodríguez-Eguren; Antonio Pellicer; Irene Cervelló
Journal:  Cells       Date:  2021-03-08       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.